Tudor Investment Corp ET AL Cuts Stake in Chemed Corporation $CHE

Tudor Investment Corp ET AL reduced its stake in Chemed Corporation (NYSE:CHE) by 81.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,106 shares of the company’s stock after selling 4,952 shares during the period. Tudor Investment Corp ET AL’s holdings in Chemed were worth $495,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. WCM Investment Management LLC boosted its stake in shares of Chemed by 3.8% in the 3rd quarter. WCM Investment Management LLC now owns 661 shares of the company’s stock valued at $299,000 after buying an additional 24 shares during the period. Eukles Asset Management raised its holdings in Chemed by 0.4% in the third quarter. Eukles Asset Management now owns 6,031 shares of the company’s stock valued at $2,700,000 after acquiring an additional 24 shares in the last quarter. Cim LLC lifted its stake in Chemed by 1.1% in the third quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after acquiring an additional 24 shares during the last quarter. Cetera Investment Advisers lifted its stake in Chemed by 1.5% in the second quarter. Cetera Investment Advisers now owns 1,740 shares of the company’s stock worth $847,000 after acquiring an additional 25 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its holdings in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after acquiring an additional 25 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Zacks Research lowered shares of Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $422.00 target price (down from $572.00) on shares of Chemed in a research note on Friday, February 27th. Oppenheimer dropped their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Finally, Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $498.00.

Chemed Price Performance

NYSE CHE opened at $378.25 on Thursday. The company has a fifty day moving average of $423.62 and a two-hundred day moving average of $433.75. The company has a market capitalization of $5.21 billion, a PE ratio of 20.59, a P/E/G ratio of 1.50 and a beta of 0.49. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $623.60.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). The firm had revenue of $639.34 million during the quarter, compared to analysts’ expectations of $659.09 million. Chemed had a net margin of 10.48% and a return on equity of 25.66%. Chemed’s quarterly revenue was down .1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.83 EPS. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, research analysts expect that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Monday, February 23rd were paid a dividend of $0.60 per share. The ex-dividend date was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s dividend payout ratio is currently 13.06%.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the sale, the chief executive officer owned 93,719 shares in the company, valued at approximately $37,785,626.42. This represents a 2.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 3.29% of the stock is currently owned by corporate insiders.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.